

Overview
Diabetic retinopathy is one of the most common and vision-threatening outcomes of long-standing diabetes, representing a key marker of systemic microvascular injury. As rates of type 2 diabetes continue to rise globally, the prevalence of this condition has increased in parallel, making retinal disease in diabetes a growing clinical and public health priority. Understanding its pathophysiology, natural history, and risk factors is crucial for effective prevention and timely detection.
Retinal disease in diabetes develops gradually, driven by chronic hyperglycemia, hypertension, and metabolic dysregulation that damage retinal microvasculature. Over time, patients may progress from mild non-proliferative changes to advanced proliferative disease or diabetic macular edema, each carrying significant risks for irreversible vision loss. Recognizing the early structural and functional changes is essential to prevent progression to late-stage complications.
Diabetic retinopathy screening plays a pivotal role in identifying disease during its asymptomatic phase. Modern screening strategies include dilated fundus examination, retinal photography, and other automated assessments. Evidence consistently shows that early detection significantly reduces blindness risk and improves long-term visual outcomes.
Advances in diabetic retinopathy treatment—from laser photocoagulation and intravitreal anti- vascular endothelial growth factor (VEGF) therapy to corticosteroid options—have transformed prognosis and preserved sight for many patients. Integrating these ophthalmic interventions with systemic risk-factor control, patient education, and coordinated multidisciplinary care is vital to comprehensive diabetes complications management. These combined approaches reflect the evolving landscape of evidence-based care for patients living with diabetes.
This lecture provides a detailed exploration of current concepts in diabetic retinopathy, including disease mechanisms, contemporary screening approaches, and effective management strategies aimed at preventing vision loss and improving patient outcomes.
At the end of this learning activity, participants should be able to:
KRISTINE G. PORMIDA, MD, DPBO
GENERAL OPHTHALMOLOGY, VITREO RETINAL SPECIALIST
Keywords: diabetic retinopathy, retinal disease in diabetes, diabetic retinopathy screening, diabetic retinopathy treatment, diabetes complications management